Drug Abuse Testing Market by Product Type, Distribution Channel, End User 2024-2032

imarc123 9 views 15 slides Jun 13, 2024
Slide 1
Slide 1 of 15
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15

About This Presentation

The global drug abuse testing market size reached US$ 7.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 12.0 Billion by 2032, exhibiting a growth rate (CAGR) of 5.9% during 2024-2032.

More Info:- https://www.imarcgroup.com/drug-abuse-testing-market


Slide Content

Global Drug Abuse Testing Market Research and Forecast Report 2024-2032 Format: PDF+EXCEL © 2023 IMARC All Rights Reserved

About IMARC Group International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all regions and industry verticals to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise. IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.

Report Highlight and Description According to the latest report by IMARC Group, titled  "Drug Abuse Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032,"  the  global drug abuse testing market size reached US$ 7.0 Billion in 2023. A drug abuse test is a non-invasive analysis of biological samples, including blood, hair, and urine, to detect the presence of illegal, prescription drugs or their metabolites. Drug abuse is the intentional use of illegal substances or the excessive use of over-the-counter (OTC) medications and prescribed psychoactive or performance-enhancing substances. Drug abuse testing helps identify infants and children at risk of exposure to illegal drugs and manage cases of acute mental state and seizure in the emergency room. Currently, it finds extensive applications in sports organizations, employers, and forensic purposes across the globe. Request for a PDF sample of this report: https://www.imarcgroup.com/drug-abuse-testing-market/requestsample

Report Description Global Drug Abuse Testing Market Trends : The rising drug production and consumption represents the primary factor driving the market growth. Additionally, the increasing number of individuals consuming alcohol and illicit drugs, such as marijuana, cocaine, and opioids, is positively influencing market growth. Moreover, drugs such as opiates, cannabinoids, cocaine, alcohol, diazepam, lysergic acid diethylamide (LSD), barbiturates, amphetamines, and ketamine are abused for their psychological impact, non-therapeutic and medicinal uses, along with other purposes, such as weight loss and enhancing athletic performance. In line with this, the rising drug dependence and substance use disorder has catalyzed market growth. Besides this, drug abuse can pose severe risks to health and safety and lower the morale and productivity of individuals. As a result, the escalating demand for drug abuse testing for employee and job applicant screening to ensure a safe workplace is propelling the market growth. Apart from this, the rising demand for urine drug testing due to rapid expansion in pain management and opioid dependency clinics is another major growth-inducing factor. Furthermore, several key players are launching automated testing and analysis for drug abuse and at-home use kits for instant drug abuse tests, thereby contributing to the market growth. Other factors, including increasing mortality due to drugs, the emerging e-commerce industry, technological advancements in drug screening or testing devices, and stringent government policies mandating drug screening, are also creating a favorable market outlook. Looking forward, IMARC Group expects the market value to reach US$ 12.0 Billion by 2032, expanding at a CAGR of 5.9% during 2024-2032. View Report TOC, Figures and Tables : https://www.imarcgroup.com/drug-abuse-testing-market

Report Segmentation Breakup by Product: Analyzers Immunoassays Analyzers Chromatographic Devices Breath Analyzers Rapid Testing Devices Urine Testing Devices Oral Fluid Testing Devices Consumables Laboratory Services   Breakup by Sample: Urine Oral Fluid (Saliva) Hair Breath Others

Report Segmentation Breakup by End User: Hospitals Diagnostic Laboratories Forensic Laboratories Workplaces Others Breakup by Region: North America Asia-Pacific Europe Latin America Middle East and Africa

Competitive Landscape with Key Players Abbott Laboratories Bio-Rad Laboratories Inc. Danaher Corporation Drägerwerk AG & Co. KGaA F. Hoffmann-La Roche AG Laboratory Corporation of America Holdings Omega Laboratories Inc. Quest Diagnostics Incorporated Siemens AG Thermo Fisher Scientific Inc. United States Drug Testing Laboratories Inc.

Key Questions Answered in the Report

Key Questions Answered in the Report

Table of Contents 1    Preface 2    Scope and Methodology     2.1    Objectives of the Study     2.2    Stakeholders     2.3    Data Sources         2.3.1    Primary Sources         2.3.2    Secondary Sources     2.4    Market Estimation         2.4.1    Bottom-Up Approach         2.4.2    Top-Down Approach     2.5    Forecasting Methodology 3    Executive Summary 4    Introduction     4.1    Overview     4.2    Key Industry Trends 5    Global Drug Abuse Testing Market     5.1    Market Overview     5.2    Market Performance     5.3    Impact of COVID-19   5.4    Market Forecast 6     Market Breakup by Product 6.1 Analyzers 6.1.1 Market Trends 6.1.2 Key Segments 6.1.2.1 Immunoassays Analyzers 6.1.2.2 Chromatographic Devices 6.1.2.3 Breath Analyzers 6.1.3 Market Forecast 6.2 Rapid Testing Devices 6.2.1 Market Trends 6.2.2 Key Segments        

Table of Contents 6.2.2.1 Urine Testing Devices 6.2.2.2 Oral Fluid Testing Devices 6.2.3 Market Forecast 6.3 Consumables 6.3.1 Market Trends 6.3.2 Market Forecast 6.4 Laboratory Services 6.4.1 Market Trends 6.4.2 Market Forecast 7 Market Breakup by Sample 7.1 Urine 7.1.1 Market Trends 7.1.2 Market Forecast 7.2 Oral Fluid (Saliva) 7.2.1 Market Trends 7.2.2 Market Forecast 7.3 Hair 7.3.1 Market Trends 7.3.2 Market Forecast 7.4 Breath 7.4.1 Market Trends 7.4.2 Market Forecast 7.5 Others 7.5.1 Market Trends 7.5.2 Market Forecast 8 Market Breakup by End User 8.1 Hospitals 8.1.1 Market Trends 8.1.2 Market Forecast For more information, visit : https://www.imarcgroup.com/drug-abuse-testing-market/toc

Partial List of Clients

Partial List of Clients

Disclaimer © 2024 IMARC All Rights Reserved This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC). Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication. IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.

Contact Us Visit us at : https://www.imarcgroup.com +1-631-791-1145 [email protected] Stay With Us:
Tags